Fluoroquinolones Inhibit, while β-Lactams Fail Against Biofilm-Producing Bacteria Isolated from Paediatric Syrups

Deborah Damilola Yusuf; Ejiro Dowe

doi:10.21705/mcbs.v10i1.721

Fluoroquinolones Inhibit, while β-Lactams Fail Against Biofilm-Producing Bacteria Isolated from Paediatric Syrups

Deborah Damilola Yusuf, Ejiro Dowe

Abstract

Background: Paediatric syrups are sugar-rich solutions widely preferred in paediatric healthcare due to their palatability, although they are highly prone to microbial contamination. Of particular concern is the presence of biofilm-producing microorganisms; existing studies have focused on contamination while overlooking the enhanced resistance mechanisms conferred by biofilm formation. This study aimed to determine the antibiogram profile of bacterial isolates from commonly prescribed paediatric syrups administered by caregivers to patients at selected healthcare centers.

Materials and Methods: A total of 392 syrup sample swabs were collected from hospitals and community sources. Bacterial isolation and identification were performed using standard microbiological methods. Biofilm production was evaluated using the test-tube method, and antibiotic susceptibility was determined via the disk diffusion method.

Results: Bacterial counts ranged from 3.0±2.0×10³ to 10.7±3.05×10³ CFU/mL, with community samples showing the highest counts. Bacterial isolates identified included Proteus vulgaris, with the highest frequency of occurrence (18.75%) > Streptococcus agalactiae, Klebsiella pneumoniae, Acinetobacter baumannii (12.59%) > Pseudomonas aeruginosa, Arthrobacter agilis, Enterococcus faecium, Enterobacter cloacae, Escherichia coli (6.25%). All isolates produced biofilms significantly different (p<0.05) from the negative control (broth tube without bacterial cells), except Arthrobacter agilis. Antibiotic susceptibility testing indicated multidrug resistance, particularly against amoxicillin and amoxicillin-clavulanate, while showing comparatively higher susceptibility to fluoroquinolones.

Conclusion: P. vulgaris was the most frequent isolate, while K. pneumoniae and A. baumannii produced the strongest biofilms. The highest resistance was observed against amoxicillin and amoxicillin-clavulanic acid, whereas fluoroquinolones remained the most effective. Paediatric syrups can harbor biofilm-producing multidrug-resistant bacteria, underscoring the importance of monitoring and safe handling.

Keywords: paediatric syrup, antibiogram profile, biofilm, bacterial isolates, test-tube method

Full Text:

PDF

References

Jamál MA, Ahmad W, Andleeb S, Ali M. Methicillin-resistant Staphylococcus aureus: Colonization and infection in burn patients. Ann Burns Fire Disasters. 2015; 28(4): 232-7, article.

Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of single- and multi-species biofilms. Nat Rev Microbiol. 2018; 16(1): 19-34, CrossRef.

Purbowati R, Utami SL. Increased expression of pap and sfa genes in biofilm-forming uropathogenic Escherichia coli associated with urinary tract infections. Mol Cell Biomed Sci. 2025; 9(2): 69-75, CrossRef.

Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019; 37(1): 177-92, CrossRef.

Giormezis N, Rechenioti A, Doumanas K. Bacteriophage resistance, adhesin's and toxin's genes profile of Staphylococcus aureus causing infections in children and adolescents. Microorganisms. 2025; 13(3): 484, CrossRef.

Syafitri A, Fitri L, Suhartono S. Endophytic bacteria in Acalypha indica L. leaves and their antimicrobial activity against Staphylococcus aureus and Candida albicans. Mol Cell Biomed Sci. 2025; 9(2): 82-90, CrossRef.

Xie Y, Wahab A, Gillis RJ, Costerton JW. Pseudomonas aeruginosa biofilm development and gene regulation. J Med Microbiol. 2017; 66(3): 265-7, article .

Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35(4): 322-32, CrossRef.

Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathogens. 2013; 9(7): e1003744, CrossRef.

Singh R, Sahore S, Kaur P, Rani A, Ray P. Biofilms: Survival and defense strategy for pathogens. Int J Med Microbiol. 2020; 310(2): 151-6, CrossRef.

Troja R, Dittmar Y, Rübler A. Management of device-associated infections. Surg Infect. 2014; 15(5): 479-85, article.

Rampedi MK, Adebola RA, Ekanem, E. Microbial contamination of paediatric syrups and implications for public health in sub-Saharan Africa. J Pediatr Pharmacol. 2024; 15(2): 101-12, article.

Rusmawantia DA, Wijaya H, Citraningtyas G, Al-Mubarak A. Pharmacists knowledge of non-sterile good compounding practice (GCP) and its implementation in Balikpapan community health centers: a cross-sectional study. Malays J Medi Res. 2025; 9(1): 11-21, CrossRef.

Mugoyela V, Mwambete KD, Microbial contamination of nonsterile pharmaceuticals in public hospital settings. Ther Clin Risk Manag. 2010; 6: 443-8, CrossRef.

Cowan ST, Steel KJ. Manual of the identification of medical bacteria. 2nd edition. Cambridge: Cambridge University Press; 1994, article.

Welch JT, Hall DC, Mandal D. Chemistry and safety of paediatric medications. Paediatric Drugs. 2012; 14(1): 1-11, article.

Lalitha MK, Thomas K, Satish R. Quality of medicines in South Asia. Indian J Med Microbiol. 2004. 22(4): 238-41, article.

Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004; 48(1): 1-14, CrossRef.

Berthold P, Hand J. Microbial contamination in oral pharmaceutical liquids. Brooklyn, New York: PharmaBooks Publishing; 2003, article.

Netish TA, Goje LA, Momoh SM. Comparative quality assessment of oral liquid antibiotics marketed in Nigeria. Afr J Pharm Pharmacol. 2018; 12(6): 70-5, article.

Chung JW. Introduction to the revised international guidelines on CLSI breakpoints for antimicrobial susceptibility testing; 2023 summary. Ann Clin Microbiol. 2023; 26(3): 51-7, CrossRef.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests 32nd Edition: Approved Standard M100-Ed32. Wayne, Pennsylvania USA: Clinical and Laboratory Standards Institute; 2022, article.

Gaur P, Hada V, Rath RS, Mohanty A, Singh P, Rukadikar A. Interpretation of antimicrobial susceptibility testing using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) breakpoints: Analysis of agreement. Cereus. 2023; 15(3): 1-8, CrossRef.

Khanom M, Shoma S, Sultana S. Quality assessment of some paediatric medicines available in Bangladesh. Bangladesh J Microbiol. 2013; 30(1-2): 17-21, article.

Janda JM, Abbott SL. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: Pluses, perils, and pitfalls. J Clin Microbiol. 2007; 45(9): 2761-64, CrossRef.

Berthold M, Hand DJ. Intelligent Data Analysis (Vol. 2). Berlin: Springer Publishers; 2003, CrossRef.

Ogbeibu, A.E. Biostatistics: A Practical Approach to Research and Data Handling. Benin City: Mindex Publishing Company Limited; 2005, article.

Atata RF, Biyaosi SY. Microbiological quality of some selected brands of tablets and syrups produced in Nigeria. Pharm Chem J. 2016; 3(3): 191-6, article.

Oludare AO, Adekahunsi TA. Contamination risk of paediatric antibiotic syrups from open-dispensing practices. J Pharm Microbiol. 2024; 14(1): 44-51, article.

Shrestha LB, Bhattarai NR, Khanal B. Antibiotic susceptibility pattern of biofilm-forming Escherichia coli from paediatric patients. BMC Microbiol. 2019; 19: 61-86, article.

Okeke N, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis. 2020; 13(11): 1640-6, CrossRef.

Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4): 406-25, article.

Gupta RS. Origin of diderm (Gram-negative) bacteria: Antibiotic selection pressure rather than endosymbiosis likely led to the evolution of bacterial cells with two membranes. Antonie van Leeuwenhoek. 2011; 100(2): 171-82, CrossRef.

Karygianni L, Ren Z, Koo H, Thurnheer T. Biofilm matrixome: Extracellular components in structured microbial communities. Trends Microbiol. 2020; 28(8): 668-81, CrossRef.

World Health Organization. WHO guidelines on good manufacturing practices: Water for pharmaceutical use (WHO Technical Report Series, No. 970). Geneva: World Health Organization; 2019, CrossRef.

Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: An emergent form of bacterial life. Nat Rev Microbiol. 2016; 14(9): 563-75, CrossRef.

Qurrotuaini SP, Wiqoyah N, Mustika A. Antimicrobial activity of ethanol extract of Centella asiatica leaves on Proteus mirabilis, Proteus vulgaris, and Yersinia enterocolitica in vitro. Mol Cell Biomed Sci. 2022; 6(3): 135-40, CrossRef.

Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2017; 6(4): 24-139, article.

DOI: https://doi.org/10.21705/mcbs.v10i1.721

Copyright (c) 2026 Molecular and Cellular Biomedical Sciences